Lingjun Li
Jiangsu Key Laboratory Of Molecular Biology For Skin Diseases And STIs, Peking Union Medical College
Nanjing, China
Nanjing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
C118P exerted potent anti-tumor effects against melanoma with induction of G2/M arrest via inhibiting the expression of BUB1B.
Journal: Journal of dermatological science
Published: June 13, 2022
Integration analysis of metabolites and single nucleotide polymorphisms improves the prediction of drug response of celecoxib.
Journal: Metabolomics : Official journal of the Metabolomic Society
Published: November 14, 2019
Predicting Pharmacokinetics Variation of Faropenem Using a Pharmacometabonomic Approach.
Journal: Journal of proteome research
Published: October 17, 2019
The retinoid derivant ECPIRM selectively exhibited anti-proliferation effects in cutaneous T-Cell lymphoma via ITK-mediated signaling pathway.
Journal: Journal of dermatological science
Published: October 14, 2019
The third-generation retinoid adapalene triggered DNA damage to induce S-phase arrest in HaCat cells.
Journal: Fundamental & clinical pharmacology
Published: August 21, 2019
Effects of 9-cis-retinoic acid on the proliferation and apoptosis of cutaneous T-cell lymphoma cells.
Journal: Anti-cancer drugs
Published: September 11, 2018
ECPIRM, a Potential Therapeutic Agent for Cutaneous T-Cell Lymphoma, Inhibits Cell Proliferation and Promotes Apoptosis via a JAK/STAT Pathway.
Journal: Anti-cancer agents in medicinal chemistry
Published: October 21, 2016
Synthesis and characterization of a new retinoic acid ECPIRM as potential chemotherapeutic agent for human cutaneous squamous carcinoma.
Journal: Anti-cancer agents in medicinal chemistry
Published: August 27, 2014
Showing 1-8 of 8
Last Updated: 09/26/2026